ENDOLOGIX INC's ticker is ELGX and the CUSIP is 29266S106. A total of 98 filers reported holding ENDOLOGIX INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $63,000 | -33.0% | 33,155 | +99.3% | 0.00% | -25.0% |
| Q2 2018 | $94,000 | +42.4% | 16,633 | +34.2% | 0.00% | +33.3% |
| Q4 2017 | $66,000 | -91.4% | 12,398 | -92.8% | 0.00% | -92.3% |
| Q3 2017 | $767,000 | -2.4% | 172,192 | +6.4% | 0.04% | -7.1% |
| Q2 2017 | $786,000 | +50.6% | 161,791 | +124.4% | 0.04% | +75.0% |
| Q1 2017 | $522,000 | -73.2% | 72,100 | -63.4% | 0.02% | -73.9% |
| Q4 2015 | $1,951,000 | +890.4% | 197,109 | +1605.7% | 0.09% | +1214.3% |
| Q1 2015 | $197,000 | -32.1% | 11,556 | -48.8% | 0.01% | -53.3% |
| Q1 2014 | $290,000 | -68.5% | 22,574 | -57.3% | 0.02% | -69.4% |
| Q4 2013 | $921,000 | +54.8% | 52,856 | +43.2% | 0.05% | +53.1% |
| Q3 2013 | $595,000 | -4.0% | 36,914 | -21.0% | 0.03% | +60.0% |
| Q2 2013 | $620,000 | – | 46,724 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Capital Management, LLC | 4,050,000 | $49,653,000 | 5.91% |
| Essex Woodlands Management, Inc. | 1,257,468 | $21,220,000 | 3.88% |
| PURA VIDA INVESTMENTS, LLC | 205,100 | $2,515,000 | 1.44% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,347,113 | $28,776,000 | 1.11% |
| First Light Asset Management, LLC | 180,963 | $2,219,000 | 1.10% |
| ArrowMark Colorado Holdings LLC | 2,889,546 | $35,426,000 | 0.97% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,149,949 | $26,358,000 | 0.78% |
| Iguana Healthcare Management, LLC | 150,000 | $1,839,000 | 0.72% |
| CADIAN CAPITAL MANAGEMENT, LP | 1,492,443 | $18,297,000 | 0.66% |
| WASHINGTON CAPITAL MANAGEMENT, INC | 85,882 | $1,053,000 | 0.66% |